Page 461 - Read Online
P. 461

Maner et al. J Cancer Metastasis Treat 2020;6:37  I  http://dx.doi.org/10.20517/2394-4722.2020.60                        Page 13 of 40








































               Figure 7. This image shows the extrinsic pathway insults including infection, stress, UV radiation, and carcinogens while the intrinsic
               pathway is due to oncogene activation [86] . UV: ultraviolet radiation; JAK: Janus kinase

               atypia. Arsenic has also been found to change the functionality of transcription factors and transcriptional
               co-activators that affect cell growth and the stromal environment in which keratinocytes reside. Genetic
               pathways of UV-induced cSCCs commonly express TP53, HRAS, or other tumor suppressor gene mutations
               leading to evasion of apoptosis. However, when analyzing the signaling pathway modulation caused by
               arsenic, many of the genes mutated are directly involved with transcription. Nrf-2, a transcription factor
               important to the homeostasis of redox reactions within keratinocytes, keeps inflammation and oxidative
               stress at bay. Gene suppression of Nrf-2 in chronically exposed arsenic human epithelial cell lines produces
                                                                [88]
               arsenic-induced malignant conversion of keratinocytes . Additionally, the transcription co-activator,
               Yap, effects keratinocytes leading to malignant transformation. Yap is only activated via phosphorylation
               by Phospho-LATS kinase in wild-type keratinocytes. With a high level of chronic arsenic exposure, Yap is
               translocated to the nucleus of keratinocytes causing increased proliferation and the eventual appearance of
                                     [90]
               dysplasia and malignancy .
               BRAF inhibitors can also affect the appearance of cSCCs. During treatment with BRAF inhibitors, cSCCs
               can spontaneously appear. There are many case reports showing that BRAF inhibitor, Sorafenib, inhibits
               PI3K, MAP kinase, and NFκB, which can reduce the release of cytokines from Langerhans cells, decreasing
                                                 [91]
               T lymphocyte response to new cSCCs . As a result, the presence of IAKs or small cSCCs on patients
               taking BRAF inhibitors has the potential to cause rapid growth of cSCCs to become lacSCC due to the lack
               of immune response against these lesions.


               Supporting stroma and vascularization
               Invasion of the stroma that supports keratinocytes is a process that maintains and even evokes aggressive
               malignant behavior in cSCC. Arsenic and UV radiation affect keratinocyte stroma similarly. Chronic
   456   457   458   459   460   461   462   463   464   465   466